Mirae Asset Global Etfs Holdings Ltd. Biotechnology

Mirae Asset Global Etfs Holdings Ltd.

$43.4 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CABA Cabaletta Bio, Inc.	$51.9M	$37,000 0.0% of portfolio	26,622	Q1 2025 Added 4.62%
BDTX Black Diamond Therapeutics, Inc.	$85M	$36,000 0.0% of portfolio	23,780	Q1 2025 Added 4.45%
SAVA Cassava Sciences Inc	$75.8M	$36,000 0.0% of portfolio	24,308	Q1 2025 Added 4.35%
BMEA Biomea Fusion, Inc.	$52.7M	$35,000 0.0% of portfolio	16,531	Q1 2025 Added 4.43%
GLSI Greenwich Life Sciences, Inc.	$115M	$34,000 0.0% of portfolio	3,638	Q1 2025 Added 4.48%
TCRX T Scan Therapeutics, Inc.	$27.3M	$32,000 0.0% of portfolio	23,238	Q1 2025 Added 4.61%
LXRX Lexicon Pharmaceuticals, Inc.	$138M	$31,000 0.0% of portfolio	68,683	Q1 2025 Added 4.41%
STRO Sutro Biopharma, Inc.	$43.3M	$31,000 0.0% of portfolio	48,998	Q1 2025 Added 4.5%
ATNM Actinium Pharmaceuticals, Inc.	$37.8M	$28,000 0.0% of portfolio	17,853	Q1 2025 Added 4.57%
APLT Applied Therapeutics Inc.	$16.3M	$28,000 0.0% of portfolio	57,557	Q1 2025 Added 4.44%
INZY Inozyme Pharma, Inc.	$160M	$28,000 0.0% of portfolio	30,982	Q1 2025 Added 4.47%
PYXS Pyxis Oncology, Inc.	$41.1M	$28,000 0.0% of portfolio	29,259	Q1 2025 Added 4.46%
ABOS Acumen Pharmaceuticals, Inc.	$48.2M	$27,000 0.0% of portfolio	25,171	Q1 2025 Added 4.54%
HLVX Hille Vax, Inc.	$62.2M	$27,000 0.0% of portfolio	19,260	Q1 2025 Added 4.22%
NAUT Nautilus Biotechnology, Inc.	$91M	$25,000 0.0% of portfolio	29,126	Q1 2025 Added 4.48%
XFOR X4 Pharmaceuticals, Inc	$183M	$24,000 0.0% of portfolio	100,693	Q1 2025 Added 4.46%
MRSN Mersana Therapeutics, Inc.	$35M	$23,000 0.0% of portfolio	68,760	Q1 2025 Added 4.28%
STTK Shattuck Labs, Inc.	$40.3M	$22,000 0.0% of portfolio	23,711	Q1 2025 Added 4.47%
RAPT Rapt Therapeutics, Inc.	$220M	$21,000 0.0% of portfolio	17,853	Q1 2025 Added 4.57%
AVTE Aerovate Therapeutics, Inc.	$65.5M	$20,000 0.0% of portfolio	8,054	Q1 2025 Added 4.03%
TNYA Tenaya Therapeutics, Inc.	$23.6M	$18,000 0.0% of portfolio	33,064	Q1 2025 Added 4.43%
HOWL Werewolf Therapeutics, Inc.	$35.7M	$18,000 0.0% of portfolio	18,651	Q1 2025 Added 4.36%
IPSC Century Therapeutics, Inc.	$34.7M	$13,000 0.0% of portfolio	27,447	Q1 2025 Added 4.45%
PEPG Pep Gen Inc.	$34.3M	$13,000 0.0% of portfolio	9,289	Q1 2025 Added 4.38%
ALXO Alx Oncology Holdings Inc	$19.6M	$12,000 0.0% of portfolio	19,771	Q1 2025 Added 4.54%
GBIO Generation Bio Co.	$22.4M	$11,000 0.0% of portfolio	29,957	Q1 2025 Added 4.35%
OVID Ovid Therapeutics Inc.	$21.1M	$11,000 0.0% of portfolio	37,012	Q1 2025 Added 4.17%
IGMS Igm Biosciences, Inc.	$33.6M	$10,000 0.0% of portfolio	9,096	Q1 2025 Added 4.48%
ELEV Elevation Oncology, Inc.	$8.85M	$7,000 0.0% of portfolio	29,433	Q1 2025 Added 5.01%
PRLD Prelude Therapeutics Inc	$33.8M	$6,000 0.0% of portfolio	7,887	Q1 2025 Added 4.12%
GALT Galectin Therapeutics Inc	$144M	$5,000 0.0% of portfolio	4,388	Q1 2025 Reduced 62.51%
LYRA Lyra Therapeutics, Inc.	$333M	$3,000 0.0% of portfolio	29,018	Q1 2025 Added 4.49%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	32,760	Q1 2025 Reduced 2.38%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.